News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
441,205 Results
Type
Article (22500)
Company Profile (164)
Press Release (418541)
Multimedia
Podcasts (74)
Webinars (13)
Section
Business (135082)
Career Advice (1055)
Deals (24579)
Drug Delivery (102)
Drug Development (53721)
Employer Resources (88)
FDA (10963)
Job Trends (10246)
News (229280)
Policy (20426)
Tag
Academia (1145)
Accelerated approval (3)
Adcomms (17)
Allergies (58)
Alliances (37612)
ALS (59)
Alzheimer's disease (764)
Antibody-drug conjugate (ADC) (99)
Approvals (10984)
Artificial intelligence (238)
Autoimmune disease (18)
Automation (16)
Bankruptcy (210)
Best Places to Work (7888)
BIOSECURE Act (14)
Biosimilars (102)
Biotechnology (79)
Bladder cancer (46)
Brain cancer (20)
Breast cancer (156)
Cancer (1379)
Cardiovascular disease (133)
Career advice (870)
Career pathing (24)
CAR-T (65)
Cell therapy (207)
Cervical cancer (7)
Clinical research (44981)
Collaboration (672)
Compensation (215)
Complete response letters (23)
COVID-19 (1373)
CRISPR (36)
C-suite (191)
Cystic fibrosis (64)
Data (1438)
Decentralized trials (2)
Denatured (19)
Depression (32)
Diabetes (181)
Diagnostics (4027)
Digital health (14)
Diversity (7)
Diversity, equity & inclusion (26)
Drug discovery (89)
Drug pricing (115)
Drug shortages (30)
Duchenne muscular dystrophy (64)
Earnings (49718)
Editorial (32)
Employer branding (10)
Employer resources (81)
Events (63950)
Executive appointments (584)
FDA (11864)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (497)
Gene editing (68)
Generative AI (23)
Gene therapy (186)
GLP-1 (631)
Government (2260)
Grass and pollen (3)
Guidances (44)
Healthcare (10081)
Huntington's disease (14)
IgA nephropathy (23)
Immunology and inflammation (90)
Indications (20)
Infectious disease (1476)
Inflammatory bowel disease (97)
Inflation Reduction Act (8)
Influenza (36)
Intellectual property (67)
Interviews (143)
IPO (10064)
IRA (45)
Job creations (2663)
Job search strategy (765)
Kidney cancer (7)
Labor market (24)
Layoffs (296)
Leadership (21)
Legal (4743)
Liver cancer (34)
Lung cancer (206)
Lymphoma (101)
Machine learning (4)
Management (32)
Manufacturing (267)
MASH (53)
Medical device (7865)
Medtech (7868)
Mergers & acquisitions (14941)
Metabolic disorders (559)
Multiple sclerosis (55)
NASH (20)
Neurodegenerative disease (55)
Neuropsychiatric disorders (24)
Neuroscience (1128)
NextGen: Class of 2025 (4012)
Non-profit (1698)
Now hiring (24)
Obesity (334)
Opinion (205)
Ovarian cancer (39)
Pain (85)
Pancreatic cancer (51)
Parkinson's disease (99)
Partnered (15)
Patents (182)
Patient recruitment (73)
Peanut (27)
People (41014)
Pharmaceutical (79)
Pharmacy benefit managers (21)
Phase I (13994)
Phase II (19007)
Phase III (15371)
Pipeline (887)
Policy (131)
Postmarket research (1718)
Preclinical (5067)
Press Release (43)
Prostate cancer (81)
Psychedelics (18)
Radiopharmaceuticals (187)
Rare diseases (276)
Real estate (4008)
Recruiting (31)
Regulatory (14874)
Reports (26)
Research institute (1202)
Resumes & cover letters (166)
Rett syndrome (3)
RNA editing (2)
RSV (27)
Schizophrenia (63)
Series A (89)
Series B (53)
Service/supplier (13)
Sickle cell disease (39)
Special edition (15)
Spinal muscular atrophy (114)
Sponsored (24)
Startups (2438)
State (2)
Stomach cancer (9)
Supply chain (68)
Tariffs (44)
The Weekly (53)
Vaccines (346)
Venture capitalists (31)
Weight loss (248)
Women's health (24)
Worklife (12)
Date
Today (1)
Last 7 days (558)
Last 30 days (1669)
Last 365 days (21858)
2025 (7328)
2024 (23428)
2023 (26141)
2022 (34473)
2021 (37155)
2020 (36139)
2019 (30387)
2018 (23053)
2017 (22450)
2016 (21221)
2015 (24265)
2014 (18900)
2013 (16085)
2012 (17245)
2011 (17451)
2010 (15663)
Location
Africa (491)
Alabama (32)
Alaska (2)
Arizona (109)
Arkansas (9)
Asia (29824)
Australia (3890)
California (3590)
Canada (1386)
China (394)
Colorado (186)
Connecticut (155)
Delaware (118)
Europe (63804)
Florida (633)
Georgia (147)
Idaho (51)
Illinois (395)
India (24)
Indiana (270)
Iowa (7)
Japan (138)
Kansas (79)
Kentucky (23)
Louisiana (5)
Maine (26)
Maryland (510)
Massachusetts (2798)
Michigan (143)
Minnesota (313)
Mississippi (2)
Missouri (61)
Montana (25)
Nebraska (18)
Nevada (34)
New Hampshire (44)
New Jersey (1277)
New Mexico (25)
New York (996)
North Carolina (712)
North Dakota (8)
Northern California (1510)
Ohio (142)
Oklahoma (8)
Oregon (29)
Pennsylvania (826)
Puerto Rico (12)
Rhode Island (24)
South America (768)
South Carolina (18)
South Dakota (1)
Southern California (1383)
Tennessee (66)
Texas (531)
United States (14603)
Utah (97)
Virginia (120)
Washington D.C. (52)
Washington State (306)
West Virginia (2)
Wisconsin (58)
441,205 Results for "piramal pharma solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
Piramal Pharma Solutions Commemorates Opening of Its ADC Manufacturing Expansion in Grangemouth, Scotland
Piramal Pharma Solutions, a Contract Development and Manufacturing Organization and part of Piramal Pharma Ltd., celebrated the opening of its expanded antibody-drug conjugate manufacturing facility in Grangemouth, Scotland, UK.
December 18, 2023
·
6 min read
Piramal Pharma Limited Announces Results for Q4 and FY2024
Piramal Pharma Limited, a leading global pharmaceuticals company, announced its standalone and consolidated results for the Fourth Quarter and Full Year ended 31st March 2024.
May 10, 2024
·
8 min read
Press Releases
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work
July 30, 2024
·
4 min read
Press Releases
Piramal Pharma’s GHG Commitment Validated and Approved by SBTi
September 16, 2024
·
3 min read
Press Releases
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
April 28, 2025
·
2 min read
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization, formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
October 17, 2023
·
4 min read
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
Piramal Pharma Limited announced its standalone and consolidated results for the Third Quarter and Nine Months ended 31st December 2023.
January 30, 2024
·
7 min read
Press Releases
Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, ‘Building Resilience for a Sustainable Tomorrow’
October 4, 2024
·
5 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
1 of 44,121
Next
